AEGON Asset Management (UK)’s PRA Health Sciences, Inc. PRAH Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2021
Q3 | – | Sell |
-14,120
| Closed | -$2.33M | – | 182 |
|
|
2021
Q2 | $2.33M | Hold |
14,120
| – | – | 0.03% | 163 |
|
|
2021
Q1 | $2.16M | Sell |
14,120
-816
| -5% | -$111K | 0.03% | 155 |
|
|
2020
Q4 | $1.87M | Hold |
14,936
| – | – | 0.03% | 157 |
|
|
2020
Q3 | $1.51M | Buy |
14,936
+1,023
| +7% | +$104K | 0.03% | 142 |
|
|
2020
Q2 | $1.35M | Hold |
13,913
| – | – | 0.03% | 145 |
|
|
2020
Q1 | $1.15M | Hold |
13,913
| – | – | 0.03% | 142 |
|
|
2019
Q4 | $1.55M | Hold |
13,913
| – | – | 0.04% | 159 |
|
|
2019
Q3 | $1.38M | Hold |
13,913
| – | – | 0.04% | 151 |
|
|
2019
Q2 | $1.38M | Hold |
13,913
| – | – | 0.04% | 151 |
|
|
2019
Q1 | $1.53M | Hold |
13,913
| – | – | 0.04% | 136 |
|
|
2018
Q4 | $1.28M | Sell |
13,913
-4,759
| -25% | -$482K | 0.04% | 137 |
|
|
2018
Q3 | $2.06M | Sell |
18,672
-3,446
| -16% | -$359K | 0.05% | 115 |
|
|
2018
Q2 | $2.06M | Hold |
22,118
| – | – | 0.05% | 117 |
|
|
2018
Q1 | $1.83M | Hold |
22,118
| – | – | 0.05% | 135 |
|
|
2017
Q4 | $2.01M | Sell |
22,118
-1,989
| -8% | -$165K | 0.05% | 118 |
|
|
2017
Q3 | $1.84M | Buy |
24,107
+8,352
| +53% | +$631K | 0.05% | 123 |
|
|
2017
Q2 | $1.18M | Sell |
15,755
-6,136
| -28% | -$425K | 0.03% | 152 |
|
|
2017
Q1 | $1.43M | Sell |
21,891
-344
| -2% | -$20.3K | 0.04% | 124 |
|
|
2016
Q4 | $1.23M | Sell |
22,235
-1,176
| -5% | -$64.5K | 0.03% | 139 |
|
|
2016
Q3 | $1.32M | Buy |
+23,411
| New | +$1.15M | 0.04% | 127 |
|
Other funds holding PRAH
AEGON Asset Management (UK)'s PRAH Position: Q3 2021 in Review
AEGON Asset Management (UK) sold out of PRA Health Sciences, Inc. (PRAH) in Q3 2021, closing a stake of 14,120 shares — an estimated $2.33M sold.
AEGON Asset Management (UK) first reported a position in PRAH in Q3 2016 and held it in 20 quarters. The position peaked at $2.33M in Q2 2021. 1 fund tracked by Wall St. Rank holds PRAH as of Q3 2021.
- AEGON Asset Management (UK) reported no remaining PRA Health Sciences, Inc. position as of Q3 2021 after selling out during the quarter.
- AEGON Asset Management (UK) sold 14,120 PRA Health Sciences, Inc. shares in Q3 2021, an estimated $2.33M.
- AEGON Asset Management (UK) first reported a position in PRA Health Sciences, Inc. in Q3 2016 and held it in 20 quarters.
- AEGON Asset Management (UK)'s PRA Health Sciences, Inc. position peaked at $2.33M in Q2 2021.
- 1 fund tracked by Wall St. Rank held PRA Health Sciences, Inc. as of Q3 2021.
Based on AEGON Asset Management (UK)'s 13F filing for Q3 2021, filed 28 Oct 2021.